|
HS Code |
594523 |
As an accredited 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As someone who’s spent years around research benches and lab procurement offices, I’ve seen the difference a thoughtfully designed intermediate can make. 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile isn’t just a complicated string of syllables. This compound builds vital bridges in the world of organic chemistry, especially for researchers hunting for selectivity and functional flexibility in their synthesis projects. With a precise balance of bromo, phenoxy, and benzonitrile groups attached to a stable benzene core, it brings unique reactivity options for those building molecules stepwise, aiming for innovation in areas like pharmaceuticals, advanced materials, and organic electronics.
The molecular formula, C14H10BrNO2, marks a framework that’s not too bulky for downstream derivatization but not too lightweight to lack functional punch. Researchers often deliberate compound purity and consistency; only a compound with a purity profile above 98% earns a place in my lab. That standard helps avoid headaches later—impurities can throw off yields, affect structural analysis, or introduce safety variables nobody wants to encounter midway through a synthesis. Typical supply forms include a white to off-white crystalline powder, signaling a good start for reproducibility and handling ease. Solubility in common organic solvents—such as DCM, acetone, and slightly in ethanol—grants flexibility depending on project demands. Stability under standard dry, room-temperature storage means fewer emergency fridge dashes or worry about degradation between orders.
The prime value of a compound like 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile comes from its charming structure. The bromo group enables targeted halogenation and a launching point for metal-catalyzed cross-coupling reactions. Suzuki, Buchwald-Hartwig, and Ullmann-type couplings come to mind. My own experience—working on regulated pharmaceutical intermediates—taught me just how much a well-placed bromo atom can mean. It presents access to myriad derivatives without lengthy protection and deprotection strategies. The para-nitrile group opens parallel windows—serving as a precursor for amides, tetrazoles, or other nitrogen-containing rings that fill libraries at pharmaceutical companies. Add the hydroxymethyl unit, and there’s a ready functional handle for further elaboration or attachment to larger molecular fragments.
It’s not only about what can be made, but why researchers choose this compound over the next candidate on their shelf. In the last decade, the drive for targeted therapies and high-performance materials energized the hunt for specific benzene derivatives that can participate in multi-step synthetic programs. My former group worked with several phenoxybenzonitriles, tracing reaction pathways and optimizing selectivity in kinase inhibitor programs. I’ve seen, firsthand, the improved yield and purity profiles when the right intermediate serves as the backbone. This molecule’s unique substitution allows for stepwise construction, letting chemists dial in activity and tune the hydrophilicity or lipophilicity of the final product.
Every ordering decision must earn its rationale. Standard benzonitriles and phenoxy derivatives crowd the catalog pages, but introducing a para-bromo alongside a meta-hydroxymethyl breaks the mold. Many routine intermediates lack this deliberate arrangement. With others, missing the hydroxyl or bromo cuts out downstream transformations. In medicinal chemistry, the structural motif provided here ties directly to active research targets like CNS ligands and anti-tumor scaffolds. The bromo group provides synthetic traction—making palladium-catalyzed couplings cleaner and more reliable. Hydroxymethyl substitution readies the core for additional appending of polar groups or labels.
Compared to symmetrical bis-phenoxybenzonitriles, this mono-bromo version avoids the steric congestion and complex purification these bulkier analogues cause. This means more reliable flash chromatography, fewer byproducts, and easier scale-up from milligrams to grams—a huge plus for process chemists planning kilo-scale runs. On the analytical side, NMR and mass spectra come out cleaner, so even entry-level researchers can troubleshoot synthesis problems with less ambiguity.
Academic labs, industrial R&D, and scale-up facilities all look to intermediates like 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile when charting a new synthetic route. I recall consulting with a group searching for novel anti-inflammatory scaffolds; their workflow started with common halogenated benzonitriles but quickly brought in this tailored intermediate to streamline two steps into one. By leveraging the ortho and para relationships among the substituents, it cut out extra protection strategies—saving time, money, and minimizing chemical waste. It’s not hype; it’s gratification earned at the fume hood after months of trial and error.
Outside the brochure language, the specs directly reflect on lab safety, reproducibility, and output. Reliability in melting point and purity turns into research confidence. I have always urged colleagues to scrutinize not only the paperwork but also material provenance. The wrong polymorph or batch-level impurity can upend a thesis or push a regulatory filing off the rails. My trust grows with each batch that delivers within one or two degrees of the stated melting range and matches the TLC and HPLC profiles on the data sheet.
Safety information also can’t be set aside. Though not a notorious hazard, this compound’s bromo and nitrile functionality calls for gloves, goggles, and appropriate ventilation—lessons I picked up after one too many surprise headaches during extended coupling reactions. Waste disposal and solvent compatibility factor in for large synthesis runs, turning a small oversight into a scale-up liability. Partnering with suppliers who consistently communicate and certify each kilogram keeps the whole operation running smoother.
In the early days of any project, time spent on procurement is time not spent building new structures. Historically, specialty intermediates suffered from uneven supply or wide batch-to-batch variability. Sourcing reliable 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile used to mean scouring specialty catalogs or engaging in custom synthesis agreements, often forcing research groups to overpay or compromise on lead times. These days, greater awareness of the structure’s utility brought more producers into the field. I’ve found lead times under two weeks with certain reputable suppliers, though sudden spikes in demand for drug discovery programs can occasionally stretch this longer.
Sustainability and traceability also matter more than ever. Green chemistry principles nudge more researchers toward intermediates produced under lower-solvent, less energy-intensive processes. As someone invested in both performance and progress, I look for documentation on manufacturing routes, trace metal analysis, and adherence to evolving environmental standards. The compound’s physical form—stable, non-hygroscopic, and amenable to scaled handling—translates into safer, more efficient operations. Each new supplier’s paperwork gets a thorough review against these priorities.
The value of a thoughtfully designed intermediate can ripple well beyond the bench. A stable, high-functionality molecule like 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile enables rapid expansion of chemical libraries. In my work on combinatorial syntheses, such building blocks shaved days off workflows by consolidating steps and reducing purification bottlenecks. For example, the benzonitrile functionality allows for quick conversion to imidazoles or isoquinolines—substructures prized in today’s medicinal chemist’s toolbox. The presence of bromo and hydroxymethyl groups greatly increases the options for generating analogues. Rather than laboriously modifying each ring or chain after the fact, researchers can use a plug-and-play approach, accelerating the speed at which meaningful compounds reach preclinical testing.
Process chemistry groups view this intermediate as a cost and safety win. Using it in direct arylation or nucleophilic substitution reactions means less need for harsh reagents or sensitive catalysts, helping companies lower their environmental impact alongside costs. In my years in industry, tight project timelines could make or break a product launch, and having a multi-functional, reliable intermediate smoothed the path from proof-of-concept all the way to pilot-scale batches. A few grams here may grow into dozens of kilos with confidence in each shipment.
Input from academics, small biotech, and big pharma shapes the way these advanced intermediates evolve. I’ve seen researchers benefit from collaborative supplier relationships where process feedback speeds up purifications and reduces side product formation. There’s ongoing demand for even higher purity material, lower trace metals, and documentation for regulatory filings. These wishes reflect a broader trend: more open communication and higher standards lead to steadier innovations for everyone.
The conversation around sustainability runs through these discussions. Efforts to reduce hazardous byproducts, recover solvents, and use renewable feedstocks mark the future direction for specialty intermediates like this one. I’ve participated in joint projects aiming to close the loop on reagent recycling and carbon management. Promoting transparency in raw material sources and adhering to ISO and green chemistry protocols builds trust beyond single transactions. The move toward improved process analytics—using in-line monitoring and tighter quality controls—paves the way for more exacting product batches and a lower chance of late-stage project hiccups.
The practicalities of working with 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile matter in day-to-day lab life. Easy weighing and dissolution in common solvents stand out—a small but important time-saver compared to viscous oils or unstable powders that cake after one open-close cycle. I remember labs that always struggled with static buildup or clumpy materials; switching to this compound turned a routine step from a frustration into a straightforward task. Storage and shipment under standard conditions help both academic and industrial users with limited cold-room or specialty storage space.
Batch documentation and support also factor into lab efficiency. A reliable supplier who answers questions on lot analysis, MSDS paperwork, or custom compatibility streamlines the onboarding for new researchers and helps established groups scale their work. Labs on tight deadlines and budget constraints benefit from knowing their intermediate will arrive consistent, ready to use, with full documentation in-hand—not piecemeal or after repeated reminders.
In regulated fields, what’s delivered must match exactly what’s tracked on manufacturing and quality systems. Pharmaceutical applications, in particular, demand a transparent supply chain, with safeguards against contamination or process deviations. As an auditor, I’ve examined certificates of analysis, MSDS, and full traceability for each intermediate, including 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile. Any uncertainty about origin, batch segregation, or residual solvents can result in costly delays or, worse, non-compliant product batches. A strong partnership between labs and suppliers—one grounded in open communication—shields research teams from these hurdles and keeps development on track.
Further downstream, handling and disposal matter just as much as procurement. The environmental health and safety departments I’ve worked with appreciate clear labeling, securely sealed containers, and chemical specificity in waste sorting. Even small improvements (like tamper-evident seals or self-desiccating packaging) can enhance safety and compliance, reducing the burden on already stretched research teams.
Recognizing the role of advanced intermediates like this one can help science move forward. Facilitating knowledge sharing and feedback between producers and end-users creates better routes for troubleshooting, adoption of cleaner technologies, and quicker adaptation when research directions shift. More open online communities and supplier platforms contribute here—sites where real users share practical tips, unexpected troubleshooting results, and small process improvements that save weeks, sometimes months, of work across laboratories worldwide.
New challenges always emerge as demands shift toward even safer, more sustainable, and versatile compounds. I see opportunities for collaboration on tailored packaging for large-scale orders, better documentation for emerging regulatory frameworks around the globe, and tools for automating ordering and reordering as research projects scale up or pivot directions. As digital supply chain tools become more widespread, traceability and transparency promise to eliminate guesswork and boost confidence at every level, whether the final destination is a startup biotech incubator or a global pharmaceutical production line.
Reflecting on my own journey through academic and industrial research, it’s clear that thoughtfully chosen intermediates like 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile mark the difference between a productive lab and one mired in troubleshooting. The structure provides a rare combination of reactive handles and manageable physical properties, meeting today’s demanding research goals while keeping an eye on tomorrow’s safety and sustainability imperatives. Every researcher, from postgraduate student to industry process lead, wins when an intermediate can shorten synthesis routes, boost product performance, and minimize environmental impact.
That’s the core strength here—a compound whose design, availability, and real-world handling remove obstacles and expand possibilities for the scientific community. Longer-term, cultivating better supplier partnerships, transparent documentation, and new process efficiencies expands both laboratory success and the industry’s positive impact on health, technology, and the environment.